L
Leland L. Fan
Researcher at Baylor College of Medicine
Publications - 95
Citations - 5523
Leland L. Fan is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Interstitial lung disease & Respiratory disease. The author has an hindex of 39, co-authored 95 publications receiving 5145 citations. Previous affiliations of Leland L. Fan include National Jewish Health & University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
Diffuse lung disease in young children: application of a novel classification scheme.
Gail H. Deutsch,Lisa R. Young,Robin R. Deterding,Leland L. Fan,Sharon D. Dell,Judy A. Bean,Alan S. Brody,Lawrence M. Nogee,Bruce C. Trapnell,Claire Langston,Eric A. Albright,Frederic B. Askin,Peter B. Baker,Pauline M. Chou,Carlyne M. Cool,Susan Coventry,Ernest Cutz,Mary M. Davis,Megan K. Dishop,Csaba Galambos,Kathleen Patterson,William D. Travis,Susan E. Wert,Frances V. White +23 more
TL;DR: This retrospective cohort study identifies a diverse spectrum of lung disorders, largely unique to young children, that will enhance accurate description and diagnosis of these disorders.
Journal ArticleDOI
Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.
TL;DR: In this paper, the authors describe a patient with pulmonary hemangiomatosis who presented with digital clubbing and bilateral interstitial pulmonary disease, and they used interferon alfa-2a for 14 months.
Journal ArticleDOI
An Official American Thoracic Society Clinical Practice Guideline: Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy
Geoffrey Kurland,Robin R. Deterding,James S. Hagood,Lisa R. Young,Alan S. Brody,Robert G. Castile,Sharon D. Dell,Leland L. Fan,Aaron Hamvas,Bettina C. Hilman,Claire Langston,Lawrence M. Nogee,Gregory J. Redding +12 more
TL;DR: Recommendations were formulated using a systematic approach to develop evidence-based guidelines on the classification, diagnosis, and management of ILD in children, focusing on neonates and infants under 2 years of age.
Journal ArticleDOI
The changing face of pleural empyemas in children: epidemiology and management.
Karen D. Schultz,Leland L. Fan,Jay Pinsky,Lyssa N. Ochoa,E. O'Brian Smith,Sheldon L. Kaplan,Mary L. Brandt +6 more
TL;DR: The microbiologic cause of empyema has changed with an increasing incidence of S a Aureus, particularly methicillin-resistant S aureus, and the use of VATS for initial therapy ofEmpyema results in decreased duration of fever and length of hospitalization.
Journal ArticleDOI
Clinical, radiological and pathological features of ABCA3 mutations in children
Minh L. Doan,Robert Paul Guillerman,Megan K. Dishop,Lawrence M. Nogee,Claire Langston,George B. Mallory,Marianna Sockrider,Leland L. Fan +7 more
TL;DR: The presentation and course of interstitial lung disease due to ABCA3 mutations are variable, and open lung biopsy and genetic testing are warranted early in the evaluation of children with a consistent clinical picture.